ABSTRACT
Cutaneous T-cell lymphomas (CTCLs) comprise a heterogeneous group of lymphoproliferative disorders characterized by the proliferation of skin-homing post-thymic T-cells. It is the second most common extranodal non-Hodgekin's lymphoma. Many variants of mycosis fungoides and CTCLs are known to date, differing in clinical, histological, and immunophenotypic characteristics. Oral involvement has also been reported rarely in CTCLs. Treatment depends on the disease stage or the type of variant. New insights into the disease and the number of emerging novel therapeutic options have made it an interesting area for dermatologists and medical oncologists.
Subject(s)
Humans , /drug therapy , /surgery , Lymphoma, T-Cell/therapy , Mycosis Fungoides/drug therapy , Mycosis Fungoides/surgery , Mycosis Fungoides/therapy , Retinoids/therapeutic useABSTRACT
Se comunican las características inmunofenotípicas de 7 pacientes (5 del sexo masculino y 2 del femenino) con el diagnóstico clínico-morfológico de linfomas cutáneos de células T, atendidos en la consulta de Hematología del Instituto de Hematología e Inmunología. La edad de los pacientes osciló entre 17 y 88 años. El inmunodiagnóstico se realizó por inmunofluorescencia directa, con un panel de anticuerpos monoclonales que incluyó marcadores linfoides B y T: CD2, CD3, CD4, CD5, CD7, CD8, CD19, CD22 y CD25. La lectura se realizó en un clitómetro de flujo FaCScan (Becton-Dickinson). Cada marcador se consideró positivo si un porcentaje mayor al 20 % de los linfocitos expresaba el antígeno. Nuestros resultados mostraron que en la mayoría de los pacientes predominó el patrón general de los linfocitos T con función auxiliadora (CD3+, CD4+, CD8-). Se corrobora que la citometría de flujo es un procedimiento más rápido y menos laborioso que otros métodos de inmunofenotipaje celular, que nos permite un diagnóstico de certeza y la aplicación de una terapia efectiva.
The immunophenotypic characteristics of 7 patients (5 males and 2 females) with the clinical-morphological diagnosis of cutaneous T-cell lymphoma that received attention at the Hematology service of the Institute of Hematology and Immunology were reported. The patients were between 17 and 88 years old. The immunodiagnosis was made by direct immunofluorescence with a panel of monoclonal antibodies that included B and T lymphoid markers: CD2, CD3, CD4; CD5, CCD7, CD8, CD19, CD22 and CD25. The reading was obtained in a FaCScan (Becton-Dickinson) flow cytometer. Every marker was considered positive if a percentage over 20 % expressed the antigen. Our results showed the prevalence of the general pattern of T lymphocytes with auxiliary function (CD3+, CD4+, CD8-). It was proved that flow cytometry is a faster and less laborious than other methods of cellular phenotyping, allowing an accurate diagnosis and the application of an effective therapy.
ABSTRACT
We studied 24 cases of cutaneous T-cell lymphomas and six cases of benign lymphoproliferative diseases of the skin (2 Jessner's lymphocytic infiltration, 2 pseudolymphoma, 2 lymphomatoid papulosis) for the presence of Epstein-Barr Virus(EBV) RNA, using the in situ hybridization(ISH) method. Among the 24 cases of cutaneous T-cell lymphomas (CTCL), 18 cases including 12 cases of mycosis fungoides(MF) were primary CTCL, and the other 6 cases were secondary CTCL. The ISH study demonstrated a positive reaction for EBER probe in 6 out of the 24 cases(25%) of CTCL, and a negative reaction for BHLF nuclear RNA probe in all the cases studied. Double-labelling immunohistochemistry/ISH studies revealed that the EBV positive cells were CD45RO positive and CD20 negative. EBV genome was not demonstrated in any benign lymphoproliferative diseases of the skin. Among the EBER positive cases, none of the 12 cases of MF demonstrated EBER signals, and 6 out of the 12(50%) cases of CTCL were positive for EBER probe. In conclusion, latent infection of EBV may play a role in the development of non-mycosis fungoides T-cell lymphomas involving the skin.